The University of Notre Dame has added Caretream's Albira system to
its In Vivo Imaging Core, part of the Notre Dame Integrated Imaging
Facility (NDIIF). With the addition of PET, SPECT, and CT capabilities,
the NDIIF will now better serve the imaging research needs of faculty
from the departments of Biology, Engineering, Physics, and Chemistry and
Biochemistry. The Albira system will immediately enable NDIIF to
support researchers studying oncology, cardiovascular, pulmonary, and
neurodegenerative disease. According to W. Matthew Leevy, PhD,
Research Professor and Managing Director of the In Vivo Imaging Core,
the Albira system provides a 3D quantitative capability to study
biological processes at the tissue and cellular level and will be used
in a wide variety of research studies. "PET imaging will provide a
critical tool for our researchers studying tumor metabolism and
proliferation. SPECT will be utilized for the development of novel
probes for the detection of cancer or infection. And CT will be valuable
to our researchers studying bone degradation and re-growth. We also
anticipate using the imaging system as an academic teaching tool for
medical physics curricula. "
attracted NDIIF to the Albira is its unprecedented advance in detector
technology. The Albira system features a unique modular architecture
that introduces an exclusive, patented single crystal detector and
associated electronics for rapid acquisition and reconstruction of
highly resolved quantitative PET and SPECT images. This approach
contrasts with the pixelated crystal technology used in most current PET
and SPECT systems today.
Leevy was also pleased by the Albira's ease of use. "Perhaps the most
surprising aspect of the Albira is that it is virtually ‘plug and play'.
The experts at Carestream and OncoVision have done an excellent job of
distilling this complex technology down to its basic elements. Image
acquisition is literally ‘push button'. We were able to collect very
nice PET and SPECT images on day one after installation."
their existing Carestream In-Vivo MS FX PRO system (used for high
resolution fluorescence, luminescence, radio-isotopic, and X-ray
imaging) and the Albira system for PET, SPECT and CT, Notre Dame now has
the ability to use seven distinct imaging modalities for their small
animal research with just two instruments.
the Albira and the MS FX PRO are part Carestream's award winning
preclinical imaging line (Frost & Sullivan the 2011 North American
Product Line Strategy Award in Preclinical Imaging Systems), and will be
on exhibit at the upcoming at the American Association of Cancer
Research (AACR) Annual Meeting in Orlando, FL, April 2-6, 2011.
For further information please visit www.mi.carestream.com
is a worldwide provider of dental and medical imaging systems and
healthcare IT solutions; molecular imaging systems for the life science
research and drug discovery/ development market segments; and X-ray film
and digital X-ray products for the non-destructive testing market.
Carestream Molecular Imaging, a division of Carestream, develops and
markets high performance digital imaging systems for in vitro and
in-vivo imaging, PET/SPECT/CT solutions, film and accessories for the
life science research, specimen radiography and drug
discovery/development market segments. For more information on
Carestream Molecular Imaging, visit www.mi.carestream.com or call 1-877-747-4357, express code 7. Outside of the United States, call 1-203-786-5657.
About OncoVision (GEM Imaging S.A.)
creates, develops and markets molecular vision systems for the
clinical and life sciences research and drug discovery markets. In
addition to the Albira system, OncoVision has also commercialized
Sentinella for radio-guided cancer surgery and nuclear medicine imaging
and Mammi for dedicated PET imaging of the breast. www.oncovision.es